Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges

被引:44
作者
Mussap, Michele [1 ]
Puxeddu, Elisabetta [2 ,3 ]
Burrai, Patrizia [2 ,3 ]
Noto, Antonio [2 ,3 ]
Cibecchini, Francesco [1 ]
Testa, Marcella [2 ,3 ]
Puddu, Melania [2 ,3 ]
Ottonello, Giovanni [2 ,3 ]
Dessi, Angelica [2 ,3 ]
Irmesi, Roberta [2 ,3 ]
Dalla Gassa, Elisabetta [2 ,3 ]
Fanni, Claudia [2 ,3 ]
Fanos, Vassilios [2 ,3 ]
机构
[1] IRCCS Univ Hosp San Martino IST, Natl Inst Canc Res, Dept Lab Med, I-16132 Genoa, Italy
[2] Univ Cagliari, Sect Neonatal Intens Care Unit, Inst Puericulture, Dept Surg, Cagliari, Italy
[3] Univ Cagliari, Neonatal Sect, Cagliari, Italy
关键词
Neonatal sepsis; preterm newborns; reference ranges; soluble CD14 subtype presepsin (sCD14-ST);
D O I
10.3109/14767058.2012.717462
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Soluble CD14 subtype (sCD14-ST), also named presepsin, is a 13 kDa truncated form of soluble CD14 (sCD14), consisting of 64 amino acid residues. Systemic inflammation and sepsis are characterized by an early, significant increase in sCD14-ST presepsin blood concentration and thus, this small polypeptide has been proposed as a novel, reliable biomarker for the management of sepsis. We enrolled twenty-six consecutive non-septic preterm newborns with gestational age (GA) between 26 and 36 weeks) admitted to NICU after the first day of life for various severe diseases. sCD14-ST presepsin was measure on whole blood samples by a rapid commercial available chemiluminescent enzyme immunoassay (CLEIA) based on a non-competitive CLEIA. The mean sCD14-ST presepsin blood level in 26 preterm newborns was 643.1 ng/L, with a standard deviation (SD) of 303.8 ng/L; the median value was 578 ng/L. Our results clearly suggest no correlation between GA and sCD14-ST presepsin blood level between 26 and 36 weeks and thus it is reasonable to adopt a unique reference range for preterm newborns.
引用
收藏
页码:51 / 53
页数:3
相关论文
共 12 条
  • [1] BAZIL V, 1991, J IMMUNOL, V147, P1567
  • [2] C reactive protein and procalcitonin. Reference intervals for preterm and term newborns during the early neonatal period
    Chiesa, Claudio
    Natale, Fabio
    Pascone, Roberto
    Osborn, John F.
    Pacifico, Lucia
    Bonci, Enea
    De Curtis, Mario
    [J]. CLINICA CHIMICA ACTA, 2011, 412 (11-12) : 1053 - 1059
  • [3] CLSI, 2004EP17A CLSI NCCLS
  • [4] ENDO S, 1994, RES COMMUN CHEM PATH, V84, P17
  • [5] Endo S, 2012, JJAM, V23, P27
  • [6] Neonatal nephrology and laboratory medicine: an effective interdisciplinary model to improve the outcome in neonatal intensive care unit
    Mussap, Michele
    Fanos, Vassilios
    [J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2011, 24 : 2 - 3
  • [7] Nores JER, 1999, EUR J IMMUNOL, V29, P265, DOI 10.1002/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.3.CO
  • [8] 2-7
  • [9] Noto A, 2012, AACC ANN M IN PRESS
  • [10] Development of a novel method for operating magnetic particles, magtration technology, and its use for automating nucleic acid purification
    Obata, K
    Segawa, O
    Yakabe, M
    Ishida, Y
    Kuroita, T
    Ikeda, K
    Kawakami, B
    Kawamura, Y
    Yohda, M
    Matsunaga, T
    Tajima, H
    [J]. JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2001, 91 (05) : 500 - 503